Proteon Therapeutics (PRTO) News Today → Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (From Weiss Ratings) (Ad) Free PRTO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsTrendsStock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 22, 2024 | seekingalpha.comRapport Therapeutics Seeks IPO For CNS Treatment ProgramsApril 24, 2024 | investing.comProtara Therapeutics Inc (TARA)February 2, 2024 | macrumors.comiPad ProNovember 5, 2023 | morningstar.comEsperion Therapeutics Inc ESPRSeptember 20, 2023 | benzinga.comThe Latest Analyst Ratings for Revance TherapeuticsJune 7, 2023 | finance.yahoo.comENLV - Enlivex Therapeutics Ltd.May 25, 2023 | benzinga.comPrelude Therapeutics Insider Trades Send a SignalMay 23, 2023 | benzinga.comGlobal Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives GrowthApril 26, 2023 | benzinga.comRAPT Therapeutics Announces FLX475 Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingFebruary 22, 2023 | benzinga.comEarly Adopter of Remote Therapeutic Monitoring Achieves Significant Clinical and Financial OutcomesJanuary 22, 2023 | finance.yahoo.comCadrenal Therapeutics Announces Pricing of Initial Public Offering (IPO)January 19, 2023 | wsj.comAdvanced Proteome Therapeutics Announces Its Proposed Plan of ArrangementJanuary 19, 2023 | marketwatch.comPeripheral Arterial Disease (PAD) Therapeutics Market 2023 Size & Segmentation Analysis with Share, Trends till 2028 [ NEW REPORT ]January 3, 2023 | benzinga.comBusiness & Academia Join Forces To Study Magic Mushroom Therapy For IBS PatientsOctober 17, 2022 | msn.comWhat 5 Analyst Ratings Have To Say About PTC TherapeuticsSeptember 22, 2022 | msn.comWhat 6 Analyst Ratings Have To Say About Revance TherapeuticsSeptember 9, 2022 | finance.yahoo.comPropella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02 for the Treatment of Advanced Prostate Cancer at ESMO Congress 2022June 15, 2022 | finance.yahoo.comProthioneTM Capsules Reduced Time to COVID-19 Clinical Resolution and Decreased Viral Load in Phase II Clinical TrialJune 3, 2022 | thestreet.comBristol-Myers To Buy Turning Point Therapeutics In $4.1 Billion Oncology DealMay 27, 2022 | bizjournals.comFlagship Pioneering launches protein startup with $75M Get Proteon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTO and its competitors with MarketBeat's FREE daily newsletter. Email Address I’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film. Take a look. PRTO Media Mentions By Week PRTO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTO News Sentiment▼0.000.78▲Average Medical News Sentiment PRTO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTO Articles This Week▼10▲PRTO Articles Average Week Get Proteon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Turnstone Biologics News Ikena Oncology News Curis News LENZ Therapeutics News Protara Therapeutics News Entera Bio News CEL-SCI News Instil Bio News Genenta Science News Passage Bio News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTO) was last updated on 5/26/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s PRIME is Set to Shock the WorldInvestorPlaceJust $9 for a Year of Winning Market InsightsBehind the MarketsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaNew Options need New Trading StrategiesNetpicks$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteon Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.